Free Trial
LON:MHC

MyHealthChecked (MHC) Share Price, News & Analysis

MyHealthChecked logo
GBX 12.28 +0.53 (+4.47%)
As of 06/13/2025 07:03 AM Eastern

About MyHealthChecked Stock (LON:MHC)

Key Stats

Today's Range
11
12.28
50-Day Range
11
15
52-Week Range
8
21
Volume
50,232 shs
Average Volume
40,733 shs
Market Capitalization
£6.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Receive MHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyHealthChecked and its competitors with MarketBeat's FREE daily newsletter.

MHC Stock News Headlines

MyHealthChecked (LON:MHC) Stock Price Up 3.8% - Here's Why
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Oberon AIM VCT Ord (OVCT.L)
Returns At MyHealthChecked (LON:MHC) Are On The Way Up
See More Headlines

MHC Stock Analysis - Frequently Asked Questions

MyHealthChecked's stock was trading at GBX 12.50 at the start of the year. Since then, MHC shares have decreased by 1.8% and is now trading at GBX 12.28.
View the best growth stocks for 2025 here
.

Shares of MHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MyHealthChecked investors own include Beowulf Mining (BEM), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Gresham House Strategic (GHS) and Greencore Group (GNC).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:MHC
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.04 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.43 million
Cash Flow
GBX 6.90 per share
Price / Cash Flow
1.78
Book Value
GBX 14.54 per share
Price / Book
0.84

Miscellaneous

Free Float
N/A
Market Cap
£6.39 million
Optionable
Not Optionable
Beta
1.37
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (LON:MHC) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners